|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-7-12
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Compared with administration in the catheterization laboratory, early treatment with glycoprotein IIb/IIIa inhibitors provides benefits to patients with ST-segment elevation myocardial infarction who undergo primary percutaneous intervention. Whether this benefit is maintained on top of a 600 mg loading dose of clopidogrel is unknown.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1875-2128
|
|
pubmed:author |
pubmed-author:AGIR-2 Investigators,
pubmed-author:BelleLoicL,
pubmed-author:BonnefoyEricE,
pubmed-author:CapelOlivierO,
pubmed-author:DebatyGuilaumeG,
pubmed-author:DubienPierre-YvesPY,
pubmed-author:El KhouryCarlosC,
pubmed-author:MercierCatherineC,
pubmed-author:PerretThibaultT,
pubmed-author:SavaryDominiqueD,
pubmed-author:SerrePatriceP
|
|
pubmed:copyrightInfo |
2010 Elsevier Masson SAS. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
103
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
285-92
|
|
pubmed:dateRevised |
2011-4-25
|
|
pubmed:meshHeading |
pubmed-meshheading:20619238-Ambulances,
pubmed-meshheading:20619238-Angioplasty, Balloon, Coronary,
pubmed-meshheading:20619238-Biological Markers,
pubmed-meshheading:20619238-Coronary Angiography,
pubmed-meshheading:20619238-Coronary Circulation,
pubmed-meshheading:20619238-Creatine Kinase,
pubmed-meshheading:20619238-Drug Administration Schedule,
pubmed-meshheading:20619238-Drug Therapy, Combination,
pubmed-meshheading:20619238-Emergency Medical Services,
pubmed-meshheading:20619238-Female,
pubmed-meshheading:20619238-France,
pubmed-meshheading:20619238-Humans,
pubmed-meshheading:20619238-Male,
pubmed-meshheading:20619238-Myocardial Infarction,
pubmed-meshheading:20619238-Platelet Aggregation Inhibitors,
pubmed-meshheading:20619238-Ticlopidine,
pubmed-meshheading:20619238-Time Factors,
pubmed-meshheading:20619238-Treatment Outcome,
pubmed-meshheading:20619238-Troponin I,
pubmed-meshheading:20619238-Tyrosine
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Prehospital high-dose tirofiban in patients undergoing primary percutaneous intervention. The AGIR-2 study.
|
|
pubmed:affiliation |
RESCUE Network, Hussel Hospital, Vienne, France.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
